Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
While I'm not one to complain when the PPS goes up a few cents from LOD, only 14K shares have moved today. That's less than $2K.
I think we'll have to wait for some real news for BMGP to see volume again. Getting back to where we should be (ie. CE removed, etc) is not really something to be lauded. Rather, it should be expected.
Anxious to see where we are in '6-8 weeks'.
GLTA!
With no corroborating way to back that up, that is also my understanding of how it was pitched, at least initially.
I think that we're not going to get a conference call with Clayton anytime soon, but it might be mission critical to have someone call and speak to him directly with these important questions. I have called him before and would call him again but I'm pretty busy with work nowadays. Any takers?
Pointless, PPS-dropping, drivel. This kind of PR is what holds BMGP back from being taken seriously. I predicted and am severely disappointed that this is how we start the week.
From Y! Board Regarding Meeting
The two days were a success. They were asked to stay onsite today for some follow up meetings. There seemed to be interest from the Gates people. We will know if they file for a grant next week. I was able to get from the spokesperson, that they went through what that process would take, so it's more than likely they will file for the grant next week. If they do, then its clear they were asked to do this formality. This should start the process, so we want to look for a PR on any grant filings. If this gets moved through quicker due to these meetings, we should really see some interest about receiving funds. I couldn't get exacts, but was told it was in the multiple Millions range.
Don't let the fear mongers try to bring up the Cepheid news. There are even more than them vying for this piece of TB detection and testing. However, even though the WHO put out an article, the endorsed product coming from the US lab is the IOBs. We should expect to see an article from at least two who visited on the IOBS. TB is a major world topic right now. They will have articles on anything they investigate in order to keep the public aware, that they are keeping this in the forefront. With LANLs endorsement, and the portability, which I was told was a session in itself, IOBs will gets its place in this space, and should lead the way.
Since they are still there visiting, we shouldn't see any updates until next week. From a small talk with Paul, they don't plan to rush and put something out late Friday or over the weekend. I would suspect they get their notes in a detailed PR for a Monday release, Tuesday at the latest. One side note I heard, this technology will not be put back on the shelf, and will continue as a priority with LANL. That is big for BMGP. Since we wont have to press them to keep it live, they know it is critical they keep moving forward.
If I can get anything else today, Ill post it. But I would expect as the day winds down and people travel back home, this should be hard to hear back, unless someone takes the point to do any weekend follow ups.
BMGP will be the front runner as far as a US backed portable detection system, with almost 100% accuracy.
I applaud this decision. No company or organization should own the rights to a genetic sequence naturally found in populations. It's the antithesis of the scientific process.
I believe that this decision would have minimal impact on HDVY which at its root is an algorithmic company, not a biotech. While I could be wrong, in all honesty I'd rather be broke in a world without gene patents than rich in a world with them.
GLTA
Smith posted on Y!
Also, if you're feeling frustrated with your portfolio and/or HDVY, go here ( http://erkie.github.com/ ) and add it as a bookmark by dragging, then navigate to either your portfolio or HDVY's site, click the bookmark, and fire away. Good stress relief!
I like seeing the volume up and NOT seeing the floor drop out.
My cursory reading of the proxy form has my hopes tempered for activity tomorrow. They seemed to be superbly explicit about exactly what was on the docket, but I am excited for those that are going to potentially get some answers to the questions we've all been wondering about.
Still happy with my holdings and learning that patience is not only a virtue, but a PITA.
GLTA!
It was very clearly there on iHub trades.
Cyclones!
An Update on the Tobin Situation
http://biz.yahoo.com/e/101007/hdvy.ob8-k.html
7-Oct-2010
Entry into a Material Definitive Agreement, Change in Directors or Principa
Item 1.01 Entry into a Material Definitive Agreement.
On October 2, 2010, Health Discovery Corporation (the "Company") entered into a Release Agreement with Richard Scott Tobin, its President, General Counsel, Principal Financial Officer, Principal Accounting Officer and a member of the Board of Directors. Under the terms of the Release Agreement, Mr. Tobin will resign from all such positions effective October 10, 2010. Due to applicable age discrimination laws, Mr. Tobin has the right to revoke the Release Agreement at any time prior to October 10, 2010.
On July 13, 2010, Mr. Tobin was informed by the two independent members of the Board of Directors that the Company was not going to renew his employment agreement when it expired on October 15, 2010, as previously announced by the Company.
On August 9, 2010, Mr. Tobin stepped down from his day-to-day management responsibilities, while remaining on Board of Directors.
As part of his employment agreement, Mr. Tobin's 4.5 million options have vested. The Company has agreed (i) to pay Mr. Tobin $271,931.07, (ii) to extend his options until January 15, 2012, and (iii) to allow Mr. Tobin to pay with a portion of his HDC shares up to $170,000 related to any option conversion tax liability. The Company expects to incur an expense of $127,164 in the fourth quarter relating to the Release Agreement.
Mr. Tobin has further agreed that for a period of three years, he will not (i) solicit proxies or consents to vote any securities HDC, (ii) engage in short selling the common stock of HDC, (iii) act alone or in concert with others to seek to control or influence the management, board of directors or policies of HDC, and (iv) cooperate with any party seeking to do any of the foregoing.
Since August 9, 2010, Thomas L. Gallagher, Executive Vice President at Health Discovery Corporation, and formerly a Vice President at Goldman, Sachs & Co. (NYSE: GS), has assumed all of Mr. Tobin's management responsibilities, in addition to his current duties. It is expected that Mr. Gallagher will be appointed President, General Counsel, Principal Financial Officer and Principal Accounting Officer.
You didn't buy seven years ago though. Those that did have held for whatever reasons they have, and hopefully it wasn't in vain. My purchase around this time last year and through cost averaging has me just slightly green at these levels, but I'm not selling. It's not because I think this is a slam dunk by any means, but I've read the releases and listened to the discussions and I feel like, in time, this company will do something bigger than it is letting on right now. I know they throw around timelines and things but ALL companies do that. Some are much better than others in keeping said timelines but HDVY isn't the worst stock in my meager portfolio in that regard.
I guess all I'm saying is that if you're basing the assessment of the company on your assessment of the IR, then you'll get one result. If you look at the potential of the IP, you'll get another. Another if you look at the quality of the scientists on board...and so on and so on. This is a multifaceted issue which currently is stagnant (and in this market stagnant isn't the worst thing that we could be facing).
I wish they were more open, of course! But it doesn't personally offend me because I know how (and you should too, right?) how science can go and others know all the loopholes in the business end. I hate pumping as much as the rest, and I stay away from sounding too sanguine if I can help it. I'm simply optimistic on this one and while I welcome two-sided discussion, those discussions should be on the merits of the company and not the expectations of the investors based on some sense of entitlement beyond what is required. Nobody likes to be double-talked, and it can seem like that sometime (notice about the warrants, status of the app, etc) but at the end of the day, these people are trying to run a business, not please us. If they succeed, we succeed. If we get flustered in an online MB, they...don't care. So I guess if I have to pick between panic pumping and panic dumping, I'll just settle a bit northward of the fence, in the distant shade of that pumping tree and far away from the wingeing bush that's keeping me up at night.
GLTA
I'm down enough that I might as well hang on and ward off anyone else that would buy this pig
The worst kind of poster. You've shown that you're too 'yella' to wait an increase in PPS because you probably bought more than you should have. If this thing goes to 0.00000001 I'll be really bummed but it wouldn't be so disastrous that I have to play internet white knight to warn the masses. If people don't do their own DD, then they'll lose more than they win probably.
You and I see the same filings and PRs from the company and you see doom and some people don't. Doesn't that tell you that there's not a universal truth to what's happening and your perceived notions may not actually be true (and of course, vice versa)? It's a gamble with any stock! This company is bringing on new people, getting sued by some people, and being courted by others. If you're not willing to let the dust settle you have no business in the <$1 stocks.
Sell, take your losses and write-off some gains, and don't let the door hit you.
The appropriate response to wild speculation is not wild conspiracy theory either. If a wild speculation is not supported by empirical evidence, you ask for said evidence and if it cannot be supplied, you discredit the theory and more often than not, the poster. I ignore 95% of the things I read on MBs and use them mainly as news aggregation for the big things, and people like smithjjj and Zenos are great for that. I'm a graduate student and I simply don't have time to always call the company for updates so I make my investment choices with DD and continue with them through community support.
At the end of the day it's all about what you expect to get out of an investment. I have meager expectations compared to some so I'm not sweating. Others aren't as realistic, or they have more on the line. And to them, I can only empathize and wish them the best of luck.
It never helps to winge about something like communication to the shareholders when that is not the company's priority. The company is doing what it's doing to be successful. If it only wants to communicate the big things, then so be it. I hold plenty of stocks where I WISH they would shut up about the little milestones. So it's a double-edged sword I guess, and I think HDVY is treating me with all the respect I would deserve from them.
I think BMGP is a fairly safe bet at these prices at least for the long-term. I'd just love to be able to tell friends about it and not feel like I'm selling snake oil. Clayton will get this company moving and hopefully we can then start making big-kid PRs.
While noting an update is totally legitimate (fidz), what a completely useless update by Joe. There is NO new information, and more damning is the repetition of predictions that are completely (and admittedly) out of his hands.
Love BMGP, Hate the IR.
Small Cap Network Coverage
Hey all,
I'm not a super savvy investor like some of you, I just try and invest in things I believe in. I know it may lose me more than I make but as a graduate student, I'm not playing with as many chips as some of you.
Not being an investor by trade I also don't really follow TA things but I saw this on my Google Finance feed (http://www.smallcapnetwork.com/Flyers-Actually-Worth-Taking-HDVY-ADY-and-IMGN-Under-the-Microscope/s/article/view/p/mid/3/id/416/) and just thought it might be of interest to some of you, even if just to show that there seems to be more momentum even in coverage.
GLTA
Bob
Volume back down on all platforms. 1M buy not real, or something wrong with it.
Strange, the volume on Google/Yahoo/iHUB all say 3.8M but my real-time Vanguard volume says last sale at 2:05ET with a total volume of 2.8M.
BMGP Updated on PinkSheets
http://www.otcmarkets.com/stock/BMGP/financials
Too funny. Information is power, they say.
Hey Q,
They said the Beta version would be out around Memorial Day. They didn't make any statement about when it would hit the App Store, which isn't even contingent on them. Steve Jobs and his cronies make those calls.
Hopefully the Beta is out to select doctors and patients as we type for a test run, and then they'll make a release when they have that all analyzed. Software development is a multistep process, one of which they're only in an intermediate stage, self-admittedly. It's nothing that they can be called on quite yet.
We need to try and stay positive (or sell, if that's your desire). It's a waiting game, hopefully one some of us will win.
GLTA
Zero shares traded at 11:15 is more than a calm before the storm. I think it's people losing interest until news, which I'm fine with. I'd rather watch it go horizontal than down.
GLTA
SVM Wins Marketing Challenge
Too bad there wasn't a cancer set!
http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20100521005614&newsLang=en
SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (OTCBB: HDVY) announced today that Support Vector Machine technology was used to take first place in solving a complex marketing problem in the recent Active Learning Challenge. The results of the Active Learning Challenge were presented this past week at the 13th International Conference on Artificial Intelligence and Statistics, in Sardinia, Italy.
The sponsors of the Active Learning Challenge, included the European Network of Excellence, Pascal2, the French Telecom Company Orange (Euronext: FTE, NYSE: FTE), Microsoft Corporation (NasdaqGS: MSFT), ETH Zurich, and the IEEE, the world’s largest professional association dedicated to advancing technological innovation and excellence for the benefit of humanity.
Teams from both industry and academia from all over the world participated in the challenge. Each team could choose any hardware, software and algorithms to solve the challenge problems. Some of the classifiers used in the Active Learning Challenge included linear classifiers, non-linear kernels, Naïve Bayes, Nearest Neighbors, Neural Networks, Bayesian Network, and Bayesian Neural Networks, Random Forests, and Support Vector Machines.
The winners of the marketing challenge included two students from the National Taiwan University, Ming-Hen Tsai and Chia-Hua Ho from the group lead by Professor Chih-Jen Lin, who successfully applied Support Vector Machines to the complex business marketing problem. The Taiwanese team finished second overall on all six challenge problems behind the team from Intel (NasdaqGS: INTC) and ahead of the team from CoreLogic (NYSE: CLGX) and eBay Inc. (NasdaqGS: EBAY).
Students under Professor Lin’s tutelage have ranked among the top participants in several past challenges, including in the 2008 IEEE World Congress of Computation Intelligence Causality Challenge and the 2009 KDD Cup, applying Support Vector Machines to a wide variety of problems.
This year the participants addressed a complex, machine learning problem of growing importance for all businesses: Building predictive models when massive amounts of unlabeled data are available and only few queries for labeled data can be placed.
In medical applications, for instance, predictive models are built to make diagnoses. For instance, blood samples or tissue images may be examined to decide whether a patient is healthy or diseased.
In the Active Learning Challenge, the participants were facing problems of document analysis, text classification, pharmacology, embryology, marketing, and ecology.
The wining strategy for the business marketing application employed Support Vector Machine technology. SVMs also ranked second on the embryology task and third on the handwriting recognition and the document analysis task, proving their versatility across many markets.
Health Discovery Corporation is a pioneer in Support Vector Technologies and has 43 issued patents and 32 pending patents in this technology and was recently awarded the prestigious MICO Award by MDB Capital Group, LLC, San Francisco, Calif., for its game-changing and disruptive technology.
530K at the time of this post.
MDB Awards
Unless we got the Mico (the big kahuna) looks like it's no awards for us. Not needed, but would have been nice.
http://www.mdb.com/bright-light-award-winners.html
Note K - RELATED PARTY TRANSACTIONS
The Company acquired a specialized cryogenic freezer system used to keep tissue samples from the Chief Executive Officer on July 11, 2008 for $9,752.
Wowsers...what's that about? Granted I've got cell cultures of my own tissue frozen down as well since I worked in a stem cell lab but that's an odd way to put that data out there. I don't think anything of it, just kind of an odd aside.
A PR in the morning about HDVY winning an award would be a nice push to keep momentum going. Even without it, I think things are setting up nicely and while some announcements might be far off, at least there's new interest in the company.
Bright Lights Conference Winners Tomorrow
I called MDB Capital Group and asked for a list of the winners of the awards for the conference. The woman that answered the phone said she'd find out and e-mail them over and I received this e-mail shortly after.
"Hello,
Tomorrow morning there will be a press relies with the name of all the Winters at the conference.
Regards,
Anafranca Pallais
Executive Assistant"
Fingers crossed!
I personally like the person at Pershing who's holding out for $1000/share. I hope he gets it haha
It was an unfortunate ending but the PPS, in my opinion, does not reflect the overall tone of the day. Hopefully we see an increase in volume tomorrow after people have had a chance to digest what they heard and we can start our slow march (or Usain Bolt sprint if Quest speaks up) back up the ladder.
GLTA
It's the sweet 11:30-12 slot too, so people can chat about it over lunch.
I thought it was going to drop too but I'm happy I was able to enhance my position and I'm not able to sit comfortably for as long as it takes.
Exactly :) I hope to see a lot more of that as people ready the funds and call their financial gurus!
I tried to post an image of his citation record but I guess that's not allowed. If you search his name in Web of Knowledge or PubMed, his research output stands alone as a feat, but more impressive is his 'Times Cited' trend. Not only does he put out great work, but his work is fundamentally accepted by the community.
Good sign
It's going to be good, solid DD that keeps the real longs around. That's why I bought HDVY initially and that's why I still hold it today.
I think that we'd be hard pressed to find a negative to this scientist joining our team. I'm excited to see what he's bringing to the table because if you do the DD on his work, he's HIGHLY prolific and productive. That's the kind of person you want at a company like HDVY. A combination of tenacity, pre-built relationships, and molecular prowess from him and the computing power and ingenuity of HDVY should be a winning combination.
Days (weeks) like this should mean very little to longs that can afford to hold. I understand that sudden price drops and volume surges will bring in traders (rather than investors) and they're just trying to make money like the rest of us. And they should be allowed to. I just don't like how some bombard the MBs with junk and TRY and either strike fear or false hope.
The world is unfortunately made of (not exclusively) people that are easily duped, and people that take advantage of that fact. Greed is a killer here, and people shouldn't invest in a company they're not comfortable with. That being said, I really wish the market operated on the principle that a company (not its chart) was something to believe in and invest your money into. You can win some, and lose some, and you need to make smart choices but at least there wouldn't be the games with the MMs and shorting, etc.
I believe in HDVY and I hope we all get to where we're trying to go with it.
I have called HDVY in the past as well as each of my other investments. You're clearly a flipper or momentum trader and that's not how I've come to appreciate this board. I invest in companies and ideas, and if I lose money doing it, at least I knew what I was investing in an idea that meant something to me. I wish you the best of luck in all your investments, honestly.
Added to ignore list.
I'd like to think he wasn't fired and would lean that way, but I have no reason to think he was or he wasn't. I wanted to see the evidence that you_asked_for_it said he had on it because that could make a big difference in the interpretation of the update. I think he'll be a great asset to HDVY, but an even greater asset if he came on good terms.
I believe you make money, and I don't mean to sound rude.
I was asking for clarification for how you know that he was there as late as 4/29 and that he wasn't fired outside of the research article.